ZNF433
gene geneOn this page
Also known as FLJ40981
Summary
ZNF433 (zinc finger protein 433, HGNC:20811) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 433 (Q8N7K0). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 163059 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 99 total
- MANE Select transcript:
NM_001308348
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20811 |
| Approved symbol | ZNF433 |
| Name | zinc finger protein 433 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40981 |
| Ensembl gene | ENSG00000197647 |
| Ensembl biotype | protein_coding |
| Entrez | 163059 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 nonsense_mediated_decay
ENST00000344980, ENST00000411841, ENST00000419886, ENST00000455504, ENST00000478765, ENST00000547560, ENST00000548669, ENST00000550507, ENST00000550745, ENST00000552904, ENST00000870917
RefSeq mRNA: 6 — MANE Select: NM_001308348
NM_001080411, NM_001308346, NM_001308348, NM_001308351, NM_001308355, NM_001308357
CCDS: CCDS45983, CCDS77240, CCDS92523, CCDS92525
Canonical transcript exons
ENST00000550507 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002367905 | 12035537 | 12035679 |
| ENSE00003646414 | 12017876 | 12017936 |
| ENSE00003663715 | 12018166 | 12018292 |
| ENSE00003930179 | 12014715 | 12016666 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 88.47.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5126 / max 81.7610, expressed in 1262 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179284 | 3.5126 | 1262 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 88.47 | gold quality |
| left testis | UBERON:0004533 | 88.11 | gold quality |
| testis | UBERON:0000473 | 87.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.17 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.87 | gold quality |
| endometrium | UBERON:0001295 | 82.51 | gold quality |
| ventricular zone | UBERON:0003053 | 81.57 | gold quality |
| calcaneal tendon | UBERON:0003701 | 81.54 | gold quality |
| body of pancreas | UBERON:0001150 | 81.52 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 80.98 | gold quality |
| kidney | UBERON:0002113 | 80.88 | gold quality |
| pancreas | UBERON:0001264 | 80.75 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 80.35 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.31 | gold quality |
| cortex of kidney | UBERON:0001225 | 79.64 | gold quality |
| cortical plate | UBERON:0005343 | 79.63 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 79.43 | gold quality |
| islet of Langerhans | UBERON:0000006 | 79.41 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 79.38 | gold quality |
| metanephros cortex | UBERON:0010533 | 78.85 | gold quality |
| thyroid gland | UBERON:0002046 | 78.77 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 78.36 | gold quality |
| muscle tissue | UBERON:0002385 | 78.13 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 77.72 | gold quality |
| esophagus mucosa | UBERON:0002469 | 77.68 | gold quality |
| tonsil | UBERON:0002372 | 77.53 | gold quality |
| apex of heart | UBERON:0002098 | 77.49 | gold quality |
| bone marrow | UBERON:0002371 | 77.28 | gold quality |
| urinary bladder | UBERON:0001255 | 77.02 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 76.97 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.75 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- ZNF433 has been identified as a candidate gene in a genome-wide association study of German multiple sclerosis patients. (PMID:20598377)
- The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma. (PMID:34439859)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp961 | ENSMUSG00000052446 |
| rattus_norvegicus | Zfp617 | ENSRNOG00000049856 |
Paralogs (15): ZNF14 (ENSG00000105708), ZNF57 (ENSG00000171970), ZNF791 (ENSG00000173875), ZNF443 (ENSG00000180855), ZNF101 (ENSG00000181896), ZNF563 (ENSG00000188868), ZNF799 (ENSG00000196466), ZNF700 (ENSG00000196757), ZNF441 (ENSG00000197044), ZNF44 (ENSG00000197857), ZNF823 (ENSG00000197933), ZNF442 (ENSG00000198342), ZNF844 (ENSG00000223547), ZNF709 (ENSG00000242852), ZNF878 (ENSG00000257446)
Protein
Protein identifiers
Zinc finger protein 433 — Q8N7K0 (reviewed: Q8N7K0)
All UniProt accessions (8): C9JQA6, C9JUV2, Q8N7K0, F8VP42, F8VTV7, F8VXJ9, F8W0C9, F8W652
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N7K0-1 | 1 | yes |
| Q8N7K0-2 | 2 |
RefSeq proteins (6): NP_001073880, NP_001295275, NP_001295277, NP_001295280, NP_001295284, NP_001295286 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (22 total): zinc finger region 19, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7K0-F1 | 74.67 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 14 (showing top):
chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GLI4_TARGET_GENES, ZNF22_TARGET_GENES, ZNF350_TARGET_GENES, DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS, INSM2_TARGET_GENES, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, PULVER_FOREY_CELLCYCLE_PEAKING_G1_S, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, MCCABE_BOUND_BY_HOXC6, REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
278 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF433 | TMEM220 | Q6QAJ8 | 475 |
| ZNF433 | SPATA31E1 | Q6ZUB1 | 447 |
| ZNF433 | OR2D3 | Q8NGH3 | 432 |
| ZNF433 | RCCD1 | A6NED2 | 420 |
| ZNF433 | THYN1 | Q9P016 | 391 |
| ZNF433 | CYLC2 | Q14093 | 372 |
| ZNF433 | CSNK1G3 | Q9Y6M4 | 358 |
| ZNF433 | OLFML2B | Q68BL8 | 353 |
| ZNF433 | SPMIP9 | Q96LM6 | 348 |
| ZNF433 | SPATA24 | Q86W54 | 330 |
| ZNF433 | SPATC1 | Q76KD6 | 323 |
| ZNF433 | DNAH7 | Q8WXX0 | 320 |
| ZNF433 | MOSPD1 | Q9UJG1 | 314 |
| ZNF433 | FHAD1 | B1AJZ9 | 313 |
| ZNF433 | PTGDR | Q13258 | 311 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF433 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF433 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF433 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF433 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP10-5 | ZNF433 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF433 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MDFI | ZNF433 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF433 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | ZNF433 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF433 | ACTA2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF433 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF433 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): ZNF433 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-1 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-3 (Two-hybrid), ACTA2 (Affinity Capture-MS), ANKHD1 (Affinity Capture-MS), ZNF433 (Two-hybrid), KRTAP10-9 (Two-hybrid), ANKHD1 (Affinity Capture-MS), ACTA2 (Affinity Capture-MS), KRTAP10-5 (Two-hybrid), KRTAP10-7 (Two-hybrid)
ESM2 similar proteins: A2RRD8, A6NHJ4, A6NK75, B4DU55, O75346, P0DPD5, P15621, P17030, P17039, P52737, Q0VGE8, Q14588, Q147U1, Q15928, Q2M3X9, Q3KNS6, Q494X3, Q4R6C2, Q5HYK9, Q5R5Q6, Q5R5S6, Q5REA0, Q5REK1, Q60585, Q61751, Q6ECI4, Q6P9Y7, Q6ZN19, Q6ZNA1, Q7Z3V5, Q86T29, Q86WZ6, Q8N141, Q8N7K0, Q8N9F8, Q8NA42, Q8NCK3, Q8NDQ6, Q8NEM1, Q8WV37
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
99 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 94 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
970 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:12016662:CAATT:C | acceptor_gain | 1.0000 |
| 19:12016664:ATT:A | acceptor_gain | 1.0000 |
| 19:12016665:TT:T | acceptor_gain | 1.0000 |
| 19:12016665:TTC:T | acceptor_loss | 1.0000 |
| 19:12016666:TCTG:T | acceptor_loss | 1.0000 |
| 19:12016667:C:CC | acceptor_gain | 1.0000 |
| 19:12018304:CACA:C | acceptor_gain | 1.0000 |
| 19:12018307:A:C | acceptor_gain | 1.0000 |
| 19:12016663:AATT:A | acceptor_gain | 0.9900 |
| 19:12016668:T:A | acceptor_loss | 0.9900 |
| 19:12016674:C:CT | acceptor_gain | 0.9900 |
| 19:12018160:CCTTA:C | donor_loss | 0.9900 |
| 19:12018161:CTTA:C | donor_loss | 0.9900 |
| 19:12018162:TTAC:T | donor_loss | 0.9900 |
| 19:12018163:TACCT:T | donor_loss | 0.9900 |
| 19:12018165:C:CG | donor_loss | 0.9900 |
| 19:12018306:CA:C | acceptor_gain | 0.9900 |
| 19:12018309:G:C | acceptor_gain | 0.9900 |
| 19:12018311:A:C | acceptor_gain | 0.9900 |
| 19:12035533:TCAC:T | donor_loss | 0.9900 |
| 19:12035534:CACCA:C | donor_loss | 0.9900 |
| 19:12035535:ACCAT:A | donor_loss | 0.9900 |
| 19:12035536:C:CT | donor_loss | 0.9900 |
| 19:12017935:CC:C | acceptor_gain | 0.9800 |
| 19:12017936:CC:C | acceptor_gain | 0.9800 |
| 19:12017937:C:CC | acceptor_gain | 0.9800 |
| 19:12034827:CA:C | donor_gain | 0.9800 |
| 19:12035531:GCTCA:G | donor_loss | 0.9800 |
| 19:12016669:G:GC | acceptor_gain | 0.9700 |
| 19:12016675:A:T | acceptor_gain | 0.9700 |
AlphaMissense
4454 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:12014986:A:C | F627L | 0.991 |
| 19:12014986:A:T | F627L | 0.991 |
| 19:12014988:A:G | F627L | 0.991 |
| 19:12015154:A:C | F571L | 0.991 |
| 19:12015154:A:T | F571L | 0.991 |
| 19:12015156:A:G | F571L | 0.991 |
| 19:12015070:A:C | F599L | 0.990 |
| 19:12015070:A:T | F599L | 0.990 |
| 19:12015072:A:G | F599L | 0.990 |
| 19:12016078:G:C | F263L | 0.990 |
| 19:12016078:G:T | F263L | 0.990 |
| 19:12016080:A:G | F263L | 0.990 |
| 19:12015994:G:C | F291L | 0.986 |
| 19:12015994:G:T | F291L | 0.986 |
| 19:12015996:A:G | F291L | 0.986 |
| 19:12016162:A:C | F235L | 0.984 |
| 19:12016162:A:T | F235L | 0.984 |
| 19:12016164:A:G | F235L | 0.984 |
| 19:12015238:G:C | F543L | 0.983 |
| 19:12015238:G:T | F543L | 0.983 |
| 19:12015240:A:G | F543L | 0.983 |
| 19:12015574:G:C | F431L | 0.981 |
| 19:12015574:G:T | F431L | 0.981 |
| 19:12015576:A:G | F431L | 0.981 |
| 19:12018257:G:C | F16L | 0.975 |
| 19:12018257:G:T | F16L | 0.975 |
| 19:12018259:A:G | F16L | 0.975 |
| 19:12015199:G:C | H556Q | 0.974 |
| 19:12015199:G:T | H556Q | 0.974 |
| 19:12016039:G:C | H276Q | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000146377 (19:12017194 GT>G,GTT), RS1000341634 (19:12029911 C>T), RS1000348481 (19:12035664 G>A), RS1000471168 (19:12031364 T>C), RS1000754956 (19:12034622 T>C), RS1000863000 (19:12025056 T>C), RS1001194014 (19:12035083 T>G), RS1001226859 (19:12035352 C>G), RS1001409645 (19:12029240 A>C), RS1001456354 (19:12027688 A>C,G), RS1001529747 (19:12028048 A>C,G), RS1001749808 (19:12015308 G>C), RS1001815925 (19:12026141 G>C), RS1001826030 (19:12026449 G>T), RS1002025155 (19:12020449 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000716_4 | Multiple sclerosis | 1.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| N-Nitrosopyrrolidine | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW46 | HEK293 eGFP-ZNF433 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.